Applied Therapeutics Expects That Its Q1 Cash And Cash Equivalents Of $146.5M Will Fund The Business Into 2026
Applied Therapeutics Expects That Its Q1 Cash And Cash Equivalents Of $146.5M Will Fund The Business Into 2026
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.